Concurrent high-grade serous carcinoma and borderline tumor demonstrating different chemo-sensitivity

[1]  W. McCluggage,et al.  Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma: Report of a Series of Cases of an Unusual Phenomenon , 2012, The American journal of surgical pathology.

[2]  D. Bodurka,et al.  Clinicodemographic factors influencing outcomes in patients with low‐grade serous ovarian carcinoma , 2011, Cancer.

[3]  C. Sung,et al.  High‐grade serous carcinoma arising in a low‐grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23‐year‐old woman , 2009, Histopathology.

[4]  I. Shih,et al.  The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma: A Morphologic and Molecular Genetic Analysis , 2007, The American journal of surgical pathology.

[5]  Chung-Liang Ho,et al.  Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors , 2004, Cancer Research.

[6]  P. Clement,et al.  Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases. , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  C. Gilks,et al.  Subclassification of Ovarian Surface Epithelial Tumors Based on Correlation of Histologic and Molecular Pathologic Data , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  S. Russell,et al.  A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes , 2004, The Journal of pathology.

[9]  I. Shih,et al.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. , 2004, The American journal of pathology.

[10]  I. Shih,et al.  Mutational Analysis of K-ras Segregates Ovarian Serous Carcinomas into Two Types: Invasive MPSC (Low-grade Tumor) and Conventional Serous Carcinoma (High-grade Tumor) , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  J. Prat,et al.  Serous Borderline Tumors of the Ovary: A Long-Term Follow-Up Study of 137 Cases, Including 18 With a Micropapillary Pattern and 20 With Microinvasion , 2002, The American journal of surgical pathology.